| Product Code: ETC7646761 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Bortezomib Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Bortezomib Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Bortezomib Market - Industry Life Cycle |
3.4 Israel Bortezomib Market - Porter's Five Forces |
3.5 Israel Bortezomib Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Israel Bortezomib Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Israel Bortezomib Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.8 Israel Bortezomib Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Bortezomib Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Israel Bortezomib Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Bortezomib Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multiple myeloma in Israel |
4.2.2 Growing awareness about the benefits of bortezomib in treating multiple myeloma |
4.2.3 Technological advancements in healthcare leading to better diagnosis and treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with bortezomib treatment |
4.3.2 Stringent regulatory requirements for drug approval and market entry in Israel |
5 Israel Bortezomib Market Trends |
6 Israel Bortezomib Market, By Types |
6.1 Israel Bortezomib Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Israel Bortezomib Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Israel Bortezomib Market Revenues & Volume, By 1mg, 2021- 2031F |
6.1.4 Israel Bortezomib Market Revenues & Volume, By 3.5mg, 2021- 2031F |
6.1.5 Israel Bortezomib Market Revenues & Volume, By 5mg, 2021- 2031F |
6.1.6 Israel Bortezomib Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Bortezomib Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Israel Bortezomib Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.2.3 Israel Bortezomib Market Revenues & Volume, By Mantle Cell Lymphoma, 2021- 2031F |
6.2.4 Israel Bortezomib Market Revenues & Volume, By Multiple Myeloma, 2021- 2031F |
6.2.5 Israel Bortezomib Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Bortezomib Market, By Dosage |
6.3.1 Overview and Analysis |
6.3.2 Israel Bortezomib Market Revenues & Volume, By Tablet, 2021- 2031F |
6.3.3 Israel Bortezomib Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.4 Israel Bortezomib Market Revenues & Volume, By Powder, 2021- 2031F |
6.3.5 Israel Bortezomib Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Bortezomib Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Bortezomib Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Israel Bortezomib Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.4 Israel Bortezomib Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.5 Israel Bortezomib Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Bortezomib Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Bortezomib Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Israel Bortezomib Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Israel Bortezomib Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Bortezomib Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Bortezomib Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Bortezomib Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Israel Bortezomib Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Israel Bortezomib Market Import-Export Trade Statistics |
7.1 Israel Bortezomib Market Export to Major Countries |
7.2 Israel Bortezomib Market Imports from Major Countries |
8 Israel Bortezomib Market Key Performance Indicators |
8.1 Patient survival rate post-bortezomib treatment |
8.2 Adoption rate of bortezomib in different regions of Israel |
8.3 Number of clinical trials and research studies conducted on bortezomib in Israel |
9 Israel Bortezomib Market - Opportunity Assessment |
9.1 Israel Bortezomib Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Israel Bortezomib Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Israel Bortezomib Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.4 Israel Bortezomib Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Bortezomib Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Israel Bortezomib Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Bortezomib Market - Competitive Landscape |
10.1 Israel Bortezomib Market Revenue Share, By Companies, 2024 |
10.2 Israel Bortezomib Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here